In-depth profiling of tumor tissue derived from malignant pleural mesothelioma patients identifies potential biomarkers predicting response to immune-checkpoint inhibitor therapy. Academic Article uri icon

Overview

publication date

  • December 3, 2023

Identity

PubMed Central ID

  • PMC11298826

Scopus Document Identifier

  • 85198214472

Digital Object Identifier (DOI)

  • 10.1016/j.gendis.2023.101189

PubMed ID

  • 39104419

Additional Document Info

volume

  • 11

issue

  • 6